España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Anebulo Pharmaceuticals
ANEB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9900
-0.12
-10.81%
At close: -
$1.15
0.16
16.16%
After Hours: Dec 19, 7:59 PM EDT
Get Report
Comment
Anebulo Pharmaceuticals (ANEB) Forecast
News
Earnings
Anebulo Pharmaceuticals (ANEB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock
Anebulo Pharmaceuticals Stock (NASDAQ: ANEB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
Benchmark Reiterates Speculative Buy on Anebu...
Benzinga Newsdesk
Thursday, November 14, 2024
Anebulo Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Wednesday, November 13, 2024
Anebulo Pharmaceuticals Q1 EPS $(0.08) Up Fro...
Benzinga Newsdesk
Tuesday, October 01, 2024
Benchmark Reiterates Speculative Buy on Anebu...
Benzinga Newsdesk
Wednesday, September 25, 2024
Anebulo Pharmaceuticals Q4 EPS $(0.05) Up Fro...
Benzinga Newsdesk
Monday, July 22, 2024
Anebulo Receives $1.9M Grant From NIDA For In...
Benzinga Newsdesk
Friday, June 07, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Friday, May 31, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Wednesday, May 15, 2024
Anebulo Pharmaceuticals Q3 EPS $(0.06) Beats ...
Benzinga Newsdesk
Wednesday, February 14, 2024
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
Jelena Martinovic
Tuesday, February 13, 2024
Anebulo Pharmaceuticals Announces Richie Cunn...
Happy Mohamed
Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate
Happy Mohamed
Thursday, January 11, 2024
Anebulo Pharmaceuticals Filed U.S. Patent Application #20240010617: Crystalline Forms Of A Cannabinoid Receptor Type 1 (Cb1) Modulator And Methods Of Use And Preparation Thereof
Charles Gross
Thursday, December 21, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, November 14, 2023
Anebulo Pharmaceuticals Q1 EPS $(0.10) Beats ...
Benzinga Newsdesk
Tuesday, October 17, 2023
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, October 12, 2023
Chief Executive Officer at Anebulo Pharmaceuticals Acquires Company Stock Options Worth 600,000 Shares
Benzinga Insights
Wednesday, October 11, 2023
Director at Anebulo Pharmaceuticals Acquires Company Stock Options Worth 26,097 Shares
Benzinga Insights
Friday, October 06, 2023
Anebulo Pharmaceuticals Inc's Richie Cunningh...
Benzinga Newsdesk
Tuesday, October 03, 2023
Benchmark Reiterates Speculative Buy on Anebu...
Benzinga Newsdesk
Friday, September 29, 2023
On September 26, 2023, Anebulo Pharmaceutical...
Benzinga Newsdesk
Monday, September 25, 2023
HC Wainwright & Co. Reiterates Buy on Anebulo...
Benzinga Newsdesk
Thursday, September 21, 2023
Maxim Group Initiates Coverage On Anebulo Pha...
Benzinga Newsdesk
Wednesday, September 20, 2023
Anebulo Pharmaceuticals Q4 EPS $(0.10) Beats $(0.12) Estimate
Happy Mohamed
Monday, September 18, 2023
Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Ane...
Benzinga Newsdesk
Tuesday, September 05, 2023
On August 29, Anebulo Pharmaceuticals Inc's Sandra A. Gardiner Notified Company Of Her Resignation As Co's Acting CFO
Happy Mohamed
Tuesday, August 22, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, August 21, 2023
Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid Intoxication
Vuk Zdinjak
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Anebulo Receives Positive Feedback From FDA O...
Benzinga Newsdesk
Thursday, May 18, 2023
Benchmark Reiterates Speculative Buy on Anebu...
Benzinga Newsdesk
Thursday, May 11, 2023
Anebulo Pharmaceuticals: Q3 Earnings Insights
Benzinga Insights
Anebulo Pharmaceuticals Q3 EPS $(0.11) Beats ...
Benzinga Newsdesk
Wednesday, March 29, 2023
Antidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication
Vuk Zdinjak
Tuesday, March 28, 2023
Anebulo Pharmaceuticals Announces Complete Ph...
Benzinga Newsdesk
Monday, March 13, 2023
Latest Executive Changes In Marijuana Industry, New Appointments & Resignations
Jelena Martinovic
Wednesday, March 08, 2023
Anebulo Pharmaceuticals Expands Its Integrated And Outsourced Solutions; Sandra Gardiner Succeeds Rex Merchant As Acting Chief Financial Officer
Happy Mohamed
Tuesday, March 07, 2023
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Tuesday, February 14, 2023
Benchmark Maintains Speculative Buy on Anebul...
Benzinga Newsdesk
Friday, February 10, 2023
Anebulo Pharmaceuticals Q2 EPS $(0.15) Misses...
Benzinga Newsdesk
Monday, January 30, 2023
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Monday, January 09, 2023
Acute Cannabinoid Intoxication: This Pharma Company's Clinical Trials To Reduce And Treat Symptoms
Joana Scopel
Anebulo Pharmaceuticals Announced Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication
Charles Gross
Monday, December 19, 2022
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Tuesday, December 06, 2022
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Thursday, November 10, 2022
Anebulo Pharmaceuticals Q1 EPS $(0.11) Down F...
Benzinga Newsdesk
Wednesday, November 02, 2022
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch